Vapotherm (VAPO) Misses Q2 EPS by 86c

Vapotherm (NYSE: VAPO) reported Q2 EPS of ($1.61), $0.86 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $13 million versus the consensus estimate of $18.35 million.

For earnings history and earnings-related data on Vapotherm (VAPO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c